Prevent revenue slippage
Did our patients get the access?
You invested in access. See whether plan policies reflect it, plan by plan. Your drug has more restrictive access than others in the same market basket and is therefore not at parity — we validate your drug’s policy and review access documents for every drug in the basket. Validate thousands of plans in hours, with real-time insight to support contract operations and find access gaps at scale.Step therapy requirement
Cascadia Mutual Health requires documented failure of two preferred agents before it will authorize Veltraxa. On this plan, Ondaresse and Timrelvo are authorized at first line.Cascadia Mutual Health
CascadiaChoice PPO
- covered lives
- 2.41M
- est. annual exposure
- ~$12.47M
restriction
Step therapy: two preferred agents required
Sample data — an invented payer and an invented product.
Quantity limit
Northlake Health Plan doubles the dispensing interval for Veltraxa — two syringes per 56 days against 28 for both comparators — halving the quantity allowed over the same period. The plan states the limit is plan-specific rather than label-derived.Northlake Health Plan
Lakeshore HMO
- covered lives
- 1.18M
- est. annual exposure
- ~$2.92M
restriction
Quantity limit: 2 syringes / 56 days
Sample data — an invented payer and an invented product.
Prescriber restriction
Ironbridge Health Partners requires a board-certified specialist, or a written attestation of specialist consultation, only for Veltraxa. Both comparators may be prescribed in primary care.Ironbridge Health Partners
Ironbridge Select EPO
- covered lives
- 0.62M
- est. annual exposure
- ~$1.95M
restriction
Prescriber restriction: specialist attestation
Sample data — an invented payer and an invented product.